Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/23/2002CN1375891A Electric connecting structure, its producing method and electric wiring method
10/23/2002CN1375556A 表达调控序列 Expression control sequence
10/23/2002CN1375505A Genetically engineering monoclonal anti-digoxin single-stranded antibody and its use
10/23/2002CN1375503A Androgen receptor compound relative protein
10/23/2002CN1375501A New osteoclast formation inhibiting factor and its coding sequence and use
10/23/2002CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use
10/23/2002CN1375277A Prevention of skin chromatosis with tyrosinase antesense oligodeoxynucleotide
10/23/2002CN1093176C Resveratrol synthase gene and its preparing process
10/23/2002CN1093175C New structure L-asparaginase engineering bacterium and its fermented culture
10/23/2002CN1093172C Hepatitis C virus and its external cell culture method
10/23/2002CA2382994A1 A method for regulating gene expression
10/22/2002US6469231 Starch branching enzyme II of potato
10/22/2002US6469230 Starch debranching enzymes
10/22/2002US6469228 Eukaryotic transposable element
10/22/2002US6469159 Methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues
10/22/2002US6469158 Synthesis, deprotection, analysis and purification of RNA and ribozymes
10/22/2002US6469155 HIgR and related domain which binds glycoprotein D of herpes simplex virus
10/22/2002US6469154 Encoded by a nucleic acid: sensor polypeptide responsive to a chemical, biological, electrical or physiological parameter, and a fluorescent protein moiety that is affected by the responsiveness of the sensor polypeptide
10/22/2002US6469153 Uses include increasing transduction efficiency of a retrovirus on target cells, possible gene therapy applications
10/22/2002US6469151 Immobilized on solid substrate; use in oligonucleotide-ligation assays (ola) and single nucleotide polymorphism detection
10/22/2002US6469149 Cdna encoding a polypeptide having l-galactono-gamma-lactone dehydrogenase activity; expression vectors; use in production of transgenic plants, biosynthesis of vitamin c
10/22/2002US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002US6469142 Components of nmda receptors that have cation-selective channels and bind glutamate and nmda (n-methyl-d-aspartate)
10/22/2002US6469141 (ramp) which is a single transmembrane protein, designated p24, or calcyon, that interacts with a c-terminal intracellular segment of the hd1 dopamine (da) receptor, use in drug screening and diagnostics
10/22/2002US6469140 Molecules of the card-related protein family and uses thereof
10/22/2002US6469139 Point mutations; for use as immunological contragestatives; pregnancy prevention
10/22/2002US6468986 Composition comprising polynucleotide and polycationic agent which exhibits net positive electrical charge at physiological ph, and is capable of mediating entry of polynucleotides into cell
10/22/2002US6468985 Administering nucleic acid molecule encoding retinoblastoma protein-interacting zinc finger protein at or adjacent to site of tumor, wherein protein comprises specified amino acid sequence and is expressed in tumor cell and reduces its growth
10/22/2002US6468984 DNA vaccine for protecting an avian against infectious bursal disease virus
10/22/2002US6468983 RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/22/2002US6468982 Orally administering composition comprising bupivacaine and dna molecules comprising dna sequence encoding antigen linked to regulatory sequences which control expression; cellsexpressing sequence generate immune response against
10/22/2002US6468978 Conjugate comprising 1 to 4 moieties covalently bound to polypeptide comprising hedgehog n-terminal domain, each being polypeptide containing 10 to 30 hydrophobic amino acids or positively charged amino acids forming transmembrane helices
10/22/2002US6468811 Light-controlled electrokinetic assembly of particles near surfaces
10/22/2002US6468810 For capturing and releasing microparticles binding an immobilized substance (protein, polypeptide, dna, restriction enzymes); purification; materials handling
10/22/2002US6468808 Water-soluble luminescent quantum dots and biomolecular conjugates thereof and related compositions and method of use
10/22/2002US6468799 Genetically modified plants with altered starch
10/22/2002US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002US6468796 Antisense oligonucleotides; gene therapy; diagnosis
10/22/2002US6468795 Apoptotic protease activating factor (apaf-1); hybridizable antisense oligonucleotides; gene expression inhibition
10/22/2002US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002US6468790 Metastatic breast and colon cancer regulated genes
10/22/2002US6468782 Cells are cultured or incubated under conditions sufficient to induce intracellular trehalose, suspended in stabilizing solution and dried to form a solid glass; storage stablility
10/22/2002US6468777 Through enhanced control and stabilization of protein production via stress proteins and the resultant protein products
10/22/2002US6468775 From a thermophilic eubacterium; polymerase shows magnesium ion dependent reverse transcriptase activity and 3'-5' exonuclease activity
10/22/2002US6468773 Obtainable from an escherichia blattae
10/22/2002US6468772 Methods of making modified polypeptides
10/22/2002US6468771 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal DNA of target cells
10/22/2002US6468767 DNA encoding a human dopamine D1 receptor and uses thereof
10/22/2002US6468762 High specificity homocysteinases
10/22/2002US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002US6468754 Vector and method for targeted replacement and disruption of an integrated DNA sequence
10/22/2002US6468753 Anthraquinone and its derivatives
10/22/2002US6468751 Method and apparatus for performing amplification of nucleic acid on supports
10/22/2002US6468750 Cell regulation factor TTO 20
10/22/2002US6468749 Sequence-dependent gene sorting techniques
10/22/2002US6468747 Presence of the bar gene under control of a camv 35s promoter,
10/22/2002US6468746 Method for selecting stabilized proteins
10/22/2002US6468745 Method for expressing a library of nucleic acid sequence variants and selecting desired traits
10/22/2002US6468739 Process for identifying secretory genes from helicobacter pylori
10/22/2002US6468738 First polypeptide fused to a filamentous phage membrane cpviii anchor domain; mutating immunoglobulin variable domain-coding nucleotide sequence in the provided genome to form library of phage particles; immunoglobulin vh polypeptide (antibody heavy
10/22/2002US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002US6468566 For producing distilled liquors having an excellent flavor by the use of yeast into which a ferulic acid decarboxylase gene has been introduced
10/22/2002US6468547 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies
10/22/2002US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002US6468544 Genetically engineered influenza a virus with an interferon-inducing phenotype wherein said virus comprises a viral genome wherein the complete ns1 coding sequences have been deleted (delns1).
10/22/2002US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002US6468538 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis
10/22/2002US6468535 Increasing the muscle mass in an animal by administering an antibody, or antigen-binding fragment of said antibody, which binds to and inhibits the activity of gdf-8 polypeptide
10/22/2002US6468530 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/22/2002US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002US6468524 AAV4 vector and uses thereof
10/22/2002US6468523 Polypeptide compositions toxic to diabrotic insects, and methods of use
10/22/2002US6468476 Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
10/22/2002US6468391 Method of making sanitary paper from chemical pulp using a single component cellulase that does not contain cellulose-building domain
10/22/2002US6467362 Reinforced lead screw with spring biased anti-backlash nut
10/22/2002CA2320842C Improvements in the formation of brassica napus f1 hybrid seeds with high oleic acid content and a reduced linolenic acid content
10/22/2002CA2218477C Rna photocleavage using texaphyrins
10/22/2002CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002CA2188447C Recombinant poxviruses with foreign polynucleotides in essential regions
10/22/2002CA2185712C Enhanced virus-mediated dna transfer
10/22/2002CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor
10/22/2002CA2140014C A brassica regulatory sequence for root-specific or root-abundant gene expression
10/22/2002CA2095335C Cell growth inhibitors
10/22/2002CA2087519C Selection of ribozymes that efficiently cleave target rna
10/22/2002CA2040437C Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
10/22/2002CA1341395C Preparation of functional human factor viii
10/20/2002CA2382766A1 Novel bovine vdj cassette, bf1h1, suitable for antigenization
10/20/2002CA2382660A1 Method of detecting lesions such as cancer and inflammation in a transgenic mouse incorporating cytokine 3' untranslated region, using the instability of mrna
10/18/2002WO2004011597A2 Primary nucleotide sequence of the agrotis segetum granulosis viris (asgv), its use in a system to dicover insecticides, and use in prevention and control of agrotis segetum insect pest
10/18/2002WO2001081401A1 Novel collectins
10/18/2002CA2445628A1 Primary nucleotide sequence of the agrotis segetum granulosis virus (asgv), insecticide discovery systems containing this sequence and prevention and controlling kits for agrotis segetum insect outbreak and spread
10/17/2002WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002WO2002082087A2 Diagnosis and treatment of enterococcus faecium related disease
10/17/2002WO2002082086A2 Detection of methicillin-resistant staphylococcus aureus (mrsa)
10/17/2002WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002WO2002082043A2 Transgenic zebrafish models for neurodegenerative diseases
10/17/2002WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002WO2002081981A2 Thermoelectric device for dna genomic and proteonic chips and thermo-optical seitching circuits
10/17/2002WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection